English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
时长
全部
短(小于 5 分钟)
中(5-20 分钟)
长(大于 20 分钟)
日期
全部
过去 24 小时
过去一周
过去一个月
去年
清晰度
全部
低于 360p
360p 或更高
480p 或更高
720p 或更高
1080p 或更高
源
全部
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
价格
全部
免费
付费
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Appr
…
7 个月之前
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
1 个月前
targetedonc.com
Future Perspectives on the Relapsed/Refractory Follicular Ly
…
1 周前
targetedonc.com
Key Updates from ARMANI in Advanced HER2- Gastric/GEJ Can
…
7 个月之前
targetedonc.com
A Need for New Therapies in High-Risk MDS
10 个月之前
targetedonc.com
Pirtobrutinib as a Game Changer for Patients With CLL
10 个月之前
targetedonc.com
Upcoming Insights – Strategies for Management of Dermatological R
…
2 周前
targetedonc.com
3:20
MONARCH 3: First-Line Abemaciclib Plus Nonsteroidal AI
…
2024年1月8日
targetedonc.com
Considerations for Treatment Sequencing in LR-MDS
1 周前
targetedonc.com
Elacestrant as second-line therapy for ESR1-mutated, endocrine-sen
…
2 个月之前
targetedonc.com
Response to Larotrectinib in NTRK Thyroid Cancer Differs By Subtype
10 个月之前
targetedonc.com
1:21
Key Takeaways on Recent Data in Breast Cancer from SABCS 2023
2023年12月16日
targetedonc.com
Axatilimab in Refractory/Recurrent cGVHD: A Promising Later-Line O
…
4 个月之前
targetedonc.com
Efficacy in Platinum-Sensitive vs Platinum-Resistant SCLC
2 个月之前
targetedonc.com
2:14
Overview of Radioiodine-Refractory Differentiated Thyroid Cancer (RA
…
2024年1月19日
targetedonc.com
Mechanism of Action: Luspatercept vs Epoetin Alfa in LR-MDS
4 个月之前
targetedonc.com
Community Oncologists Show Comfort With Bispecifics in B-Cel
…
3 个月之前
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L
…
8 个月之前
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
7 个月之前
targetedonc.com
3:27
Update from KATHERINE on Adjuvant T-DM1 for Residual Inva
…
2024年1月11日
targetedonc.com
T-DXd Shows Promise in Treating HER2 Breast Cancer With Brain M
…
4 个月之前
targetedonc.com
Newly Diagnosed mHSPC: First-Line Treatment Options
1 个月前
targetedonc.com
Brain Benefits: Targeted Therapy Offers New Weapon Against HER
…
7 个月之前
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in
…
6 个月之前
targetedonc.com
Overview of Graft-Versus-Host Disease
4 个月之前
targetedonc.com
IO Trials Change Practice in Localized and Metastatic Bladder
…
1 个月前
targetedonc.com
Updated Trial and Real-World Data Show Benefit of Ide-Cel for Multipl
…
11 个月之前
targetedonc.com
ESMO 2024: Updates in NIAGARA Study
4 个月之前
targetedonc.com
ASH 2024 Preview for Community Oncologists: The Show and After
…
2 个月之前
targetedonc.com
The Future of Bispecific Therapy for R/R Multiple Myeloma
1 个月前
targetedonc.com
观看更多视频
更多类似内容
反馈